The Elekta Unity high-field MR-linac is now CE marked. (Courtesy: Elekta) Elekta has announced that its Unity MRI-guided radiotherapy system (MR/RT) system has received the CE mark, clearing the ...

ATLANTA, July 19, 2019 /PRNewswire/ -- Elekta (EKTA-B.ST) today announced that its Elekta Unity magnetic resonance radiation therapy (MR/RT) system has achieved regulatory certification from the ...

Demonstrates commitment to providing patients with personalized precision radiation medicine for multiple cancer indications TÜBINGEN, Germany, July 11, 2019 /PRNewswire/ -- Less than one year after ...

CHRISTCHURCH, New Zealand, June 1, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announces that St George's Hospital in Christchurch, New Zealand, has ordered an Elekta Unity MR-Linac, making it the 100th ...

Elekta Unity combines advanced diagnostic standard MR imaging and precision radiotherapy technologies, giving doctors the “vision” to zero in on tumors and avoid healthy tissues On July 25, the ...

Advances in magnetic resonance radiation therapy (MR/RT) has the potential to transform accuracy, efficiency and clinical outcomes in radiation therapy. Elekta (EKTA-B.ST) announced that Elekta Unity, ...

STOCKHOLM – Elekta (EKTA-B.ST) announced today that its MR-Linac, Elekta Unity, has received CE mark for its Comprehensive Motion Management with True Tracking and automatic gating functionalities.

The Elekta Unity MRI-guided radiotherapy system can now be implemented clinically in the US. (Courtesy: Elekta) The Elekta Unity MRI-guided radiotherapy system has received 510(k) premarket ...

Elekta (EKTA-B.ST) earlier today announced (14:15 CET) that its Elekta Unity magnetic resonance radiation therapy (MR/RT) system has received CE mark, clearing the technology for commercial sales and ...

VIENNA – Elekta (EKTA-B.ST) today announced that Elekta Unity MR-Linac clinical users presented 93 abstracts highlighting how the high-field magnetic resonance guided radiation therapy (MRgRT) ...

New radiation therapy system will now be implemented clinically in Europe, ushering in a transformation in precision andpersonalized cancer treatment Elekta (EKTA-B.ST) earlier today announced (14:15 ...